Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06772493 · ClinicalTrials.gov registry record
ViewFlex X ICE First-in-Human Study
A clinical trial of Cardiac Arrhythmias, sponsored by Abbott Medical Devices.
- Recruiting
- Registry status
- 500
- Enrollment target
- 7
- Study locations
NCT06772493: Recruiting study of Cardiac Arrhythmias, sponsored by Abbott Medical Devices.
NCT06772493 is a study of Cardiac Arrhythmias that is actively recruiting participants, run by Abbott Medical Devices. The registered enrollment target is 500 participants, above the 442-participant average among 5 other Cardiac Arrhythmias trials with a reported enrollment target (13% higher). The trial reports 7 study locations across 7 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06772493, a study of Cardiac Arrhythmias, is actively recruiting participants, sponsored by Abbott Medical Devices.
- RECRUITING
- Registry status
- 500 participants
- Enrollment target
- 7
- Study locations
Study Summary
This prospective, acute, first-in-human, non-significant risk study is intended to evaluate a modified version of the ViewFlex X ICE Catheter, Sensor Enabled (ViewFlex X SE) and ViewMate Multi Ultrasound Console (VMM) ICE data integration with the EnSite X EP System (hereafter referred to as the ViewFlex X ICE System).
Conditions Studied
Interventions
- DEVICE ViewFlex X ICE System
Study Locations (7)
Arkansas
- St. Bernards Medical Center - Jonesboro
California
- University of California, San Diego - La Jolla
Missouri
- Research Medical Center - Kansas City
New York
- NYU Langone Health - New York
Pennsylvania
- Hospital of the University of Pennsylvania - Philadelphia
South Carolina
- Medical University of South Carolina - Charleston
Texas
- Houston Methodist Hospital - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2024-12-16 |
| Est. Completion | 2026-06 |
What NCT06772493 shows while recruiting
NCT06772493 is an observational study that tracks outcomes without assigning an intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap, above the 442-participant average among 5 other Cardiac Arrhythmias trials with a reported enrollment target (13% higher).
The record links to 1 condition, with Cardiac Arrhythmias appearing as the primary indexed condition, and to 1 intervention - of which ViewFlex X ICE System is the first listed.
NCT06772493 lists 7 locations in 7 states (Arkansas, California, Missouri).
Frequently Asked Questions
What is clinical trial NCT06772493 about?
NCT06772493 is a clinical study titled "ViewFlex X ICE First-in-Human Study". This prospective, acute, first-in-human, non-significant risk study is intended to evaluate a modified version of the ViewFlex X ICE Catheter, Sensor Enabled (ViewFlex X SE) and ViewMate Multi Ultrasound Console (VMM) ICE data integration with the EnSite X EP System (hereafter referred to as the Vie...
What is the current status of trial NCT06772493?
This trial is currently recruiting. The enrollment target is 500 participants. The study started on 2024-12-16. Estimated completion is 2026-06.
What conditions does trial NCT06772493 study?
This clinical trial studies the following conditions: Cardiac Arrhythmias.
What interventions are being tested in trial NCT06772493?
The interventions under investigation include: ViewFlex X ICE System (DEVICE).
Who is sponsoring clinical trial NCT06772493?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06772493 being conducted?
This trial has 7 study locations across Arkansas, California, Missouri, New York, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiac Arrhythmias
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Observational Study of Cardiac Arrhythmias During Treatment With BTK Inhibitors or Venetoclax
RECRUITING
-
EluPro Antibiotic-Eluting BioEnvelope Registry
RECRUITING
-
Confirm Rx Insertable Cardiac Monitor SMART Registry
ACTIVE NOT RECRUITING
-
Clinical Utility and Validation of the Rhythmia Mapping System for the Treatment of Cardiac Arrhythmias
COMPLETED
-
Screening for Sleep Apnea in Patients Undergoing Atrial Fibrillation Ablation
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
- NCT00697411 · 500 participants
Study of Selected X-Linked Disorders: Aicardi Syndrome
- NCT00903110 · 500 participants
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI